RO7617991
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 04, 2024
A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Genentech, Inc. | N=210 ➔ 0 | Recruiting ➔ Withdrawn
Enrollment change • Metastases • Trial withdrawal • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1